Thoracoscopic Sympathectomy




Sympathectomy is a surgical procedure where portions of the sympathetic nerve trunk are destroyed to treat diseases such as hyperhidrosis (HH), facial blushing, and Raynaud disease. Sympathectomy itself is a relatively easy procedure to perform. It is difficult, however, to access the nerve tissue in the chest cavity by conventional surgical methods. Thoracoscopy has become a standard approach for performing sympathectomy and has led to a resurgence of this procedure for a variety of diseases.


Indications


There are several indications for the treatment of HH (palmar or axillary): craniofacial sweating, facial blushing, and social phobia. Other indications for sympathectomy include Raynaud disease, reflex sympathetic dystrophy (RSD), causalgia, long QT syndrome, and untreatable angina pectoris.




Nonsurgical Treatment


It is generally thought that patients undergoing thoracoscopic sympathectomy should have previously attempted a trial of nonoperative therapy. Patients with HH are generally offered topical agents such as Drysol (aluminum hydroxide). Occasionally a trial of iontophoresis is appropriate if the patient can tolerate the side effects of tingling and electrical shocks. Oral agents have been used with some success in patients with HH, including a trial of antidepressants or other psychotropic medications, which may allow the patient to “deal with” the psychological trauma caused by the socially debilitating symptoms of HH. Other medications, like β-blockers and cholinergics, do have a significant chance of resulting in some improvement in HH with, however, side effects such as fatigue, bradycardia, and dry mouth.




Surgical Techniques


Conventional approaches include the posterior approach and the supraclavicular approach, which is less painful than the posterior but is more prone to damaging important nerves and blood vessels. In recent years, minimally invasive surgical techniques have been developed that have made endoscopic thoracic sympathectomy (ETS) possible and popular.





Surgical Anatomy





  • Each sympathetic trunk consists of a long chain of nerve ganglia lying along either side of the spine and is broadly divided into three segments: cervical, thoracic, and lumbar. The autonomic nervous system controls involuntary body functions, such as breathing, sweating, and blood pressure. The most common area targeted in sympathectomy is the upper thoracic region, the part of the sympathetic chain lying between the first and fifth thoracic vertebrae ( Fig. 23-1 ).




    figure 23-1



  • The upper sympathetic thoracic ganglion (T1) is the ganglion most responsible for sweating and heat loss of the face, hands, and to a minor degree the axillae T1, in conjunction with the eighth cervical ganglion form the stellate ganglion, which is responsible for the eyelid and pupillary response. They should be preserved because an injury may cause Horner syndrome.



  • The second thoracic ganglion (T2) controls the sweat response of the hands and face (except the interorbital portion), scalp, shoulders, and the anterior and posterior parts of the thorax above the breasts and contributes to facial blushing.



  • The third ganglion (T3) affects the sweating of the hands, axillae, shoulders, and anterior and posterior parts of thorax above the breast and of the face to a minor degree.



  • The fourth ganglion (T4) innervates the hands and the axillae. It should be noted that there is duplicate sympathetic innervation for the hands, face, and axillae.



  • ETS cuts or destroys the sympathetic ganglia, the collections of nerve cell bodies in clusters along the thoracic or lumbar spinal cord.






Preoperative Considerations





  • Dermatologists, neurologists, endocrinologists, and cardiologists involved in diagnosing or treating HH should be consulted to evaluate the patient before referral to surgical treatment.



  • Contraindications before surgery are rare but include severe cardiovascular insufficiency or pulmonary insufficiency; severe pleural diseases (tracheobronchitis, pleuritis, empyema); and uncontrolled diabetes. Prior thoracic surgery, although perhaps difficult, is not an absolute contraindication.



Level of Sympathectomy





  • Currently, a T2 sympathectomy is performed for craniofacial hyperhidrosis and facial blushing and T3 and T4 for hyperhidrosis palmaris or axillary hyperhidrosis with palmar hyperhidrosis. For long QT syndrome, the sympathetic chain is sectioned from the level of the inferior third of the stellate ganglion (T1) to the sympathetic ganglia of T5, together with any branch that courses to the caudal region or in the lateral direction.



  • We prefer cutting to clipping or coagulating the ganglia of the sympathetic trunk. The purported advantages of clipping are that the clips could be removed in case of severe side effects, such as compensatory HH and gustatory sweating and could also avoid lesions in the adjacent intercostal structures.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 13, 2019 | Posted by in CARDIOLOGY | Comments Off on Thoracoscopic Sympathectomy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access